Skip to content

Month: Settembre 2020

Popofsky S, Noor A, Leavens-Maurer J, et al. Impact of Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Detection on Breastfeeding Due to Infant Separation at Birth [published online ahead of print, 2020 Aug 10]. J Pediatr. 2020;S0022-3476(20)30986-0. doi:10.1016/j.jpeds.2020.08.004

Objective: To assess the impact of separation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR)-positive mother-newborn dyads on breastfeeding outcomes. Study design: This observational longitudinal cohort

APPROFONDISCI

Di Mascio D; WAPM (The World Association of Perinatal Medicine) working group on COVID-19. Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection [published online ahead of print, 2020 Sep 14]. Ultrasound Obstet Gynecol. 2020;10.1002/uog.23107. doi:10.1002/uog.23107

Objectives: To evaluate maternal and perinatal outcomes of pregnant women affected by SARS-COV-2. Methods: This was a multinational retrospective cohort study including women with laboratory-confirmed SARS-COV-2 from 73 centers from

APPROFONDISCI

Kanburoglu MK, Tayman C, Oncel MY, et al. A Multicentered Study on Epidemiologic and Clinical Characteristics of 37 Neonates With Community-acquired COVID-19. Pediatr Infect Dis J. 2020;39(10):e297-e302. doi:10.1097/INF.0000000000002862

Background: Coronavirus disease 2019 (COVID-19) primarily affects adults and spares children, whereas very little is known about neonates. We tried to define the clinical characteristics, risk factors, laboratory, and imagining results

APPROFONDISCI

Furtado RHM, Berwanger O, Fonseca HA, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial [published online ahead of print, 2020 Sep 4]. Lancet. 2020;S0140-6736(20)31862-6. doi:10.1016/S0140-6736(20)31862-6

Background: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes

APPROFONDISCI
assignment_turned_in Registrations

    
     
   
Please login to view this page.
Please login to view this page.
Please login to view this page.
No item in the cart
Go shopping!